Literature DB >> 8910009

Molecular characterization of the large heavily glycosylated domain glycopeptide from the rat small intestinal Muc2 mucin.

N G Karlsson1, M E Johansson, N Asker, H Karlsson, S J Gendler, I Carlstedt, G C Hansson.   

Abstract

The largest high-glycosylated domain, glycopeptide A, of the "insoluble' mucin complex of the rat small intestine has earlier been purified and characterized (Carlstedt et al., 1993, J Biol Chem 268: 18771-81). A rabbit antiserum raised against deglycosylated glycopeptide A was used to clone part of a mucin showing homology to the human MUC2 mucin (Hansson et al., 1994, Biochem Biophys Res Commun 198. 181-90). This serum specifically stained goblet cells (paranuclear) in the mouse small intestine. The size of the coding sequence of glycopeptide A was estimated by using reversed transcriptase PCR of mRNA from an inbred rat strain (GOT-W) using primers in the unique central and C-terminal parts of the proposed rat Muc2 sequences. The PCR and Southern blot of the PCR products showed a fragment of about 5.5 kb corresponding to about 1700 amino acids when the known Cys-rich sequences used for the primers were subtracted. This is slightly larger than the size estimated earlier by biochemical studies. The mRNA encoding the rat Muc2 was slightly smaller than the mRNA encoding the human MUC2 in a colorectal cell line. Although the size of glycopeptide A estimated from biochemical results and by PCR is not identical, the results obtained here further support that the "insoluble' mucin of the rat small intestine is encoded by the Muc2 gene. Most of the oligosaccharides in glycopeptide A were either neutral (40%) or sialylated (40%). The remaining ones were sulfated with the sulfate group attached to C-6 of N-acetylglucosamine linked to C-6 of the N-acetylgalactosaminitol as revealed by tandem mass spectrometry of the perdeuteroacetylated oligosaccharides. Eighteen oligosaccharides were found of which fourteen were characterized and found to be mostly novel. Our findings thus expand the current knowledge of the core peptide of the rat intestinal goblet cell mucin and provide a relatively complete picture of the glycosylation of a defined mucin domain.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910009     DOI: 10.1007/bf00702346

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  17 in total

1.  The human MUC2 intestinal mucin has cysteine-rich subdomains located both upstream and downstream of its central repetitive region.

Authors:  J R Gum; J W Hicks; N W Toribara; E M Rothe; R E Lagace; Y S Kim
Journal:  J Biol Chem       Date:  1992-10-25       Impact factor: 5.157

2.  Molecular cloning of complementary DNAs encoding alkaline phosphatase in human colon cancer cells.

Authors:  J R Gum; J W Hicks; T L Sack; Y S Kim
Journal:  Cancer Res       Date:  1990-02-15       Impact factor: 12.701

3.  Molecular cloning of the amino-terminal region of a rat MUC 2 mucin gene homologue. Evidence for expression in both intestine and airway.

Authors:  H Ohmori; A F Dohrman; M Gallup; T Tsuda; H Kai; J R Gum; Y S Kim; C B Basbaum
Journal:  J Biol Chem       Date:  1994-07-08       Impact factor: 5.157

4.  Human intestinal mucin-like protein (MLP) is homologous with rat MLP in the C-terminal region, and is encoded by a gene on chromosome 11 p 15.5.

Authors:  G Xu; L Huan; I Khatri; U S Sajjan; D McCool; D Wang; C Jones; G Forstner; J Forstner
Journal:  Biochem Biophys Res Commun       Date:  1992-03-16       Impact factor: 3.575

5.  The transcripts of the apomucin genes MUC2, MUC4, and MUC5AC are large and appear as distinct bands.

Authors:  D Baeckström; G C Hansson
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

6.  Molecular cloning of a cDNA coding for a region of an apoprotein from the 'insoluble' mucin complex of rat small intestine.

Authors:  G C Hansson; D Baeckström; I Carlstedt; K Klinga-Levan
Journal:  Biochem Biophys Res Commun       Date:  1994-01-14       Impact factor: 3.575

7.  Sialylation and sulfation of the carbohydrate chains in respiratory mucins from a patient with cystic fibrosis.

Authors:  J M Lo-Guidice; J M Wieruszeski; J Lemoine; A Verbert; P Roussel; G Lamblin
Journal:  J Biol Chem       Date:  1994-07-22       Impact factor: 5.157

8.  Sulfated sialyl-oligosaccharides derived from tracheobronchial mucous glycoproteins of a patient suffering from cystic fibrosis.

Authors:  T P Mawhinney; D C Landrum; D A Gayer; G J Barbero
Journal:  Carbohydr Res       Date:  1992-11-04       Impact factor: 2.104

9.  cDNA for the carboxyl-terminal region of a rat intestinal mucin-like peptide.

Authors:  G Xu; L J Huan; I A Khatri; D Wang; A Bennick; R E Fahim; G G Forstner; J F Forstner
Journal:  J Biol Chem       Date:  1992-03-15       Impact factor: 5.157

10.  Strategy for the investigation of O-linked oligosaccharides from mucins based on the separation into neutral, sialic acid- and sulfate-containing species.

Authors:  N G Karlsson; H Karlsson; G C Hansson
Journal:  Glycoconj J       Date:  1995-02       Impact factor: 2.916

View more
  12 in total

Review 1.  Shigella: a model of virulence regulation in vivo.

Authors:  Benoit Marteyn; Anastasia Gazi; Philippe Sansonetti
Journal:  Gut Microbes       Date:  2012-03-01

2.  Design of a specific colonic mucus marker using a human commensal bacterium cell surface domain.

Authors:  Yves-Marie Coïc; Francoise Baleux; Ömer Poyraz; Roman Thibeaux; Elisabeth Labruyere; Fabrice Chretien; Iradj Sobhani; Thierry Lazure; Benjamin Wyplosz; Gunter Schneider; Laurence Mulard; Philippe J Sansonetti; Benoit S Marteyn
Journal:  J Biol Chem       Date:  2012-03-16       Impact factor: 5.157

3.  Gastrointestinal mucins of Fut2-null mice lack terminal fucosylation without affecting colonization by Candida albicans.

Authors:  Elizabeth A Hurd; Jessica M Holmén; Gunnar C Hansson; Steven E Domino
Journal:  Glycobiology       Date:  2005-06-15       Impact factor: 4.313

4.  Identification of transient glycosylation alterations of sialylated mucin oligosaccharides during infection by the rat intestinal parasite Nippostrongylus brasiliensis.

Authors:  N G Karlsson; F J Olson; P A Jovall; Y Andersch; L Enerbäck; G C Hansson
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

5.  Intestinal mucins from cystic fibrosis mice show increased fucosylation due to an induced Fucalpha1-2 glycosyltransferase.

Authors:  Kristina A Thomsson; Marina Hinojosa-Kurtzberg; Karin A Axelsson; Steven E Domino; John B Lowe; Sandra J Gendler; Gunnar C Hansson
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

6.  Human MUC5AC mucin dimerizes in the rough endoplasmic reticulum, similarly to the MUC2 mucin.

Authors:  N Asker; M A Axelsson; S O Olofsson; G C Hansson
Journal:  Biochem J       Date:  1998-10-15       Impact factor: 3.857

7.  Duodenal-content reflux into the esophagus leads to expression of Cdx2 and Muc2 in areas of squamous epithelium in rats.

Authors:  Manuel Pera; Miguel Pera; Carmen de Bolós; Maria J Brito; Antonio Palacín; Luis Grande; Antonio Cardesa; Richard Poulsom
Journal:  J Gastrointest Surg       Date:  2007-07       Impact factor: 3.452

Review 8.  The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system.

Authors:  Thaher Pelaseyed; Joakim H Bergström; Jenny K Gustafsson; Anna Ermund; George M H Birchenough; André Schütte; Sjoerd van der Post; Frida Svensson; Ana M Rodríguez-Piñeiro; Elisabeth E L Nyström; Catharina Wising; Malin E V Johansson; Gunnar C Hansson
Journal:  Immunol Rev       Date:  2014-07       Impact factor: 12.988

9.  Cystic fibrosis mice lacking Muc1 have reduced amounts of intestinal mucus.

Authors:  R R Parmley; S J Gendler
Journal:  J Clin Invest       Date:  1998-11-15       Impact factor: 14.808

10.  Cloning, annotation and developmental expression of the chicken intestinal MUC2 gene.

Authors:  Zhengyu Jiang; Todd J Applegate; Amy C Lossie
Journal:  PLoS One       Date:  2013-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.